|
Presentations in this session:
16:30
THAC0301 | Introduction: the importance of HIV/STI interactions
J. Peter Figueroa, Jamaica
| 16:40
THAC0302
Abstract | Incidence of genital ulcers and HSV+ genital ulcers in trial of HSV-2 suppression to prevent HIV acquisition (HPTN 039)
Presented by Jorge Sanchez, Peru
C. Celum1, A. Wald2, J. Hughes3, J. Sanchez4, S. Reid5, S. Delaney-Moretlwe6, F. Cowan7, J. Fuchs8, B. Koblin9, S. Rose10, S. Griffith10, L. Corey11, HPTN 039 Protocol Team
1University of Washington, Dept of Global Health, Seattle, United States, 2University of Washington, Medicine, Lab Medicine, Epidemiology, Seattle, United States, 3University of Washington, Biostatistics, Seattle, United States, 4IMPACTA, Lima, Peru, 5Centre for Infectious Disease Research in Zambia, Lusaka, Zambia, 6Reproductive Health and HIV Research Unit, University of Witwaterstrand, Johannesburg, South Africa, 7Royal Free and University College Medical School, University College, London, United Kingdom, 8San Francisco Department of Public Health, San Francisco, United States, 9New York Blood Center, New York, United States, 10Family Health International, Raleigh, United States, 11Fred Hutchinson Cancer Research Center, Program in Infectious Diseases, Seattle, United States
| 16:55
THAC0303
Abstract
Powerpoint (336 KB) | Impact of acyclovir on ulcer healing and HIV-1 lesional and genital shedding among patients with genital ulcer disease in Malawi: a randomized controlled trial
Presented by Sam Phiri, Malawi
S. Phiri1, I. Hoffman2, H. Weiss3, W. Miller2, F. Martinson4, N. Nyirenda4, D. Kamwendo4, S. Fiscus2, C. Chen5, L. van der Hoeven6, D. Chilongozi4, M. Cohen2, P. Mayaud7
1Kamuzu Central Hospital, Lighthouse Trust, Lilongwe, Malawi, 2University of North Carolina, Chapel Hill, United States, 3London School of Hygiene & Tropical Medicine, Infectious Disease Epidemiology Unit, London, United Kingdom, 4University of North Carolina Project, Lilongwe, Malawi, 5Centres for Disease Control and Prevention, Atlanta, United States, 6Reproductive Health Unit of Ministry of Health,, Lilongwe, Malawi, 7London School of Hygiene & Tropical Medicine, Clinical Research Unit, London, United Kingdom
| 17:10
THAC0304
Abstract
Powerpoint (720 KB) | Risk factors associated with HIV incidence in HSV-2 seropositive Tanzanian women in a RCT of HSV-2 suppressive therapy
Presented by Deborah Watson-Jones, United Kingdom
D. Watson-Jones1, H. Weiss1, M. Rusizoka2, K. Baisley3, K. Mugeye2, J. Changalucha3, D. Everett3, C. Tanton3, T. Clayton1, D. Ross1, R. Hayes1
1London School of Hygiene & Tropical Medicine, London, United Kingdom, 2African Medical & Research Foundation, Mwanza, Tanzania, United Republic of, 3National Institute for Medical Research, Mwanza, Tanzania, United Republic of
| 17:25
THAC0305
Abstract
Powerpoint (499 KB) | Mycoplasma genitalium and risk of HIV acquisition among women in Zimbabwe
Presented by Sue Napierala, United Kingdom
S. Napierala1, B. Van Der Pol2, C. Kwok3, H. Weiss1, T. Chipato4, A. van der Straten5, R. Salata6, C. Morrison3
1London School of Hygiene and Tropical Medicine, Department of Epidemiology and Population Health, Infectious Disease Epidemiology Unit, London, United Kingdom, 2Indiana University School of Medicine, Indianapolis, United States, 3Family Health International, Research Triangle Park, United States, 4UZ-UCSF Collaborative Research Programme, Harare, Zimbabwe, 5RTI International, San Francisco Office Project, San Francisco, United States, 6Case Western University, Cleveland, United States
| 17:40
THAC0306
Abstract
Powerpoint (380 KB) | Prevalence of human papillomavirus (HPV) genotypes in HIV-1 infected women in Seattle, WA, and Nairobi, Kenya: results from the Women HIV Interdisciplinary Network (WHIN) program
Presented by Amneris E. Luque, United States
A.E. Luque1, J. Hitti2, C. Mwachari3, C.A. Lane1, S. Messing4, S.E. Cohn1, R.C. Rose1, R.W. Coombs5
1University of Rochester, Infectious Diseases Division, Rochester, NY, United States, 2University of Washington Medical Center, Obstetrics/Gynecology, Seattle, WA, United States, 3Kenya Medical Research Center, Centre for Respiratory Disease Research, Nairobi, Kenya, 4University of Rochester, Biostatistics and Computational Biology, Rochester, NY, United States, 5University of Washington, Laboratory Medicine, Seattle, WA, United States
|
|